Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,859 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma.
Saitta C, Garofano G, Afari JA, Tanaka H, Patil D, Yuen KL, Wang L, Cortes J, Meagher MF, Puri D, Cerrato C, Nguyen MV, Hakimi K, Kobayashi M, Fukuda S, Paciotti M, Lazzeri M, Lughezzani G, Buffi NM, Fujii Y, Master V, Derweesh IH. Saitta C, et al. Among authors: cortes j. Clin Genitourin Cancer. 2024 Dec;22(6):102232. doi: 10.1016/j.clgc.2024.102232. Epub 2024 Oct 11. Clin Genitourin Cancer. 2024. PMID: 39481317
Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry.
Saitta C, Afari JA, Patil D, Tanaka H, Yuen KL, Wang L, Cortes J, Liu F, Mahmood M, Matian J, Mansour M, Puri D, Cerrato C, Nguyen MV, Hakimi K, Kobayashi M, Fukuda S, Meagher MF, Fujii Y, Master V, Derweesh IH. Saitta C, et al. Among authors: cortes j. Clin Genitourin Cancer. 2024 Jun;22(3):102098. doi: 10.1016/j.clgc.2024.102098. Epub 2024 Apr 18. Clin Genitourin Cancer. 2024. PMID: 38733897
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry.
Cortes JA, Saitta C, Yuen KL, Patil D, Tanaka H, Puri D, Afari JA, Mahmood M, Matian J, Mansour M, Ahdoot A, Wang L, Meagher MF, Guer M, Dabbas M, Nguyen MV, Cerrato C, Kobayashi M, Fukuda S, Fujii Y, Master V, Derweesh IH. Cortes JA, et al. Clin Genitourin Cancer. 2024 Oct;22(5):102126. doi: 10.1016/j.clgc.2024.102126. Epub 2024 May 27. Clin Genitourin Cancer. 2024. PMID: 38972196
Gray-brown macules on the face and neck.
Cortes J, Hinds B, Kaunitz G. Cortes J, et al. JAAD Case Rep. 2023 Sep 7;41:30-32. doi: 10.1016/j.jdcr.2023.08.038. eCollection 2023 Nov. JAAD Case Rep. 2023. PMID: 37842162 Free PMC article. No abstract available.
HER2DX genomic test in early-stage HER2-positive breast cancer.
Tolaney SM, Tung N, Wolff AC, DeMichele A, Cejalvo JM, Martínez-Sáez O, Pascual T, Waks AG, Martín M, Ciruelos E, Harbeck N, Carey LA, Cortés J, Curigliano G, Prat A. Tolaney SM, et al. Among authors: cortes j. ESMO Open. 2024 Dec;9(12):103987. doi: 10.1016/j.esmoop.2024.103987. Epub 2024 Nov 16. ESMO Open. 2024. PMID: 39710442 Free PMC article. Review.
Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit.
Cortés JA, Valderrama-Rios MC, Peçanha-Pietrobom PM, Júnior MS, Diaz-Brochero C, Robles-Torres RR, Espinosa-Almanza CJ, Nocua-Báez LC, Nucci M, Álvarez-Moreno CA, Queiroz-Telles F, Rabagliati R, Rojas-Fermín R, Finquelievich JL, Riera F, Cornejo-Juárez P, Corzo-León DE, Cuéllar LE, Zurita J, Hernández AR, Colombo AL. Cortés JA, et al. Braz J Infect Dis. 2024 Dec 21;29(1):104495. doi: 10.1016/j.bjid.2024.104495. Online ahead of print. Braz J Infect Dis. 2024. PMID: 39709887 Free article.
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis.
Schettini F, Nucera S, Pascual T, Martínez-Sáez O, Sánchez-Bayona R, Conte B, Buono G, Lambertini M, Punie K, Cejalvo JM, Arpino G, Vigneri P, Generali D, Ciruelos E, Cortés J, Gennari A, Muñoz M, Vidal Losada MJ, Tolaney SM, Prat A, Villacampa G. Schettini F, et al. Among authors: cortes j. Cancer Treat Rev. 2024 Dec 19;132:102865. doi: 10.1016/j.ctrv.2024.102865. Online ahead of print. Cancer Treat Rev. 2024. PMID: 39709655 Free article. Review.
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2+ early breast cancer (EBC).
Fernandez-Martinez A, Tanioka M, Ahn SG, Zagami P, Pascual T, Rediti M, Tang G, Hoadley KA, Venet D, Rashid NU, Spears PA, Di Cosimo S, de Azambuja E, Choudhury A, Rastogi P, Islam MN, Cortes J, Llombart-Cussac A, Swain SM, Sotiriou C, Prat A, Perou CM, Carey LA. Fernandez-Martinez A, et al. Among authors: cortes j. Ann Oncol. 2024 Dec 18:S0923-7534(24)04989-5. doi: 10.1016/j.annonc.2024.12.010. Online ahead of print. Ann Oncol. 2024. PMID: 39706338 Free article.
Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE study.
Hughes TP, Saglio G, Geissler J, Kim DW, Lomaia E, Mayer J, Turkina A, Kapoor S, Cardoso AP, Nieman B, Quenet S, Cortes JE. Hughes TP, et al. Among authors: cortes je. J Hematol Oncol. 2024 Dec 18;17(1):125. doi: 10.1186/s13045-024-01642-6. J Hematol Oncol. 2024. PMID: 39696526 Free PMC article. Clinical Trial.
2,859 results